Optimal Omega-3 Sources and Supplementation Guide
Best food sources ranked by EPA+DHA content per serving: (1) Mackerel (100g raw): 2.6g EPA+DHA — the highest of any food. (2) Salmon (100g raw): 1.8-2.5g EPA+DHA depending on species and source — wild-caught Pacific salmon is highest. (3) Herring (100g): 1.7g. (4) Sardines (100g, canned in oil): 1.5g. (5) Anchovies (100g): 1.5g. (6) Rainbow trout (100g): 0.9g. (7) Tuna (canned, 100g): 0.3g. Two servings of fatty fish weekly provides approximately 500-1000mg EPA+DHA daily — the amount associated with primary cardiovascular prevention benefits in most guidelines.
Supplementation guidance: for general wellness in people eating 0-1 serving of fatty fish weekly, 500-1000mg combined EPA+DHA daily from fish oil or krill oil. Choose a brand with third-party testing for purity (NSF, IFOS, or USP certification) — fish oils can oxidize and contaminate with heavy metals and PCBs. Krill oil provides omega-3s as phospholipids (better absorbed than triglyceride form in fish oil) plus astaxanthin (antioxidant). For depression or cardiovascular risk reduction, 2-3g EPA+DHA daily. For hypertriglyceridemia or high-risk cardiovascular patients, 4g EPA-only (prescription or high-purity concentrate) under medical supervision.
Plant-based omega-3 strategy: for vegans and vegetarians who want adequate EPA and DHA without fish or fish oil, algal oil is the evidence-based solution. Algae are the original source of marine omega-3s (fish accumulate EPA and DHA by eating algae and plankton). Algal oil supplements provide meaningful EPA and DHA in doses comparable to fish oil — without the sustainability concerns of fish oil production or the contaminant risks. Additionally, maximizing ALA conversion by reducing omega-6 intake (cutting seed/vegetable oils), ensuring adequate cofactors (zinc, magnesium, B6, biotin support delta-6 desaturase), and eating high-ALA foods (flaxseed, chia, hemp, walnuts) alongside algal oil provides comprehensive omega-3 coverage for plant-based diets.
Testing omega-3 status: the Omega-3 Index (percentage of EPA+DHA in red blood cell membranes) is the most validated biomarker of long-term omega-3 status. An index below 4% is high-risk; 4-8% is intermediate; above 8% is low-risk for cardiovascular events (associated with risk comparable to non-smokers vs smokers for cardiovascular death). Most Americans test at 4-5%; most Japanese (who eat fatty fish 3-4 times weekly) test at 8-11%. Home testing kits are available from OmegaQuant and similar companies. Testing provides individualized guidance: some people have genetic variants that dramatically reduce conversion efficiency and need higher supplementation doses to achieve optimal index values.